A van der Does-van den Berg
Overview
Explore the profile of A van der Does-van den Berg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kamps W, Veerman A, van Wering E, van Weerden J, Slater R, van der Does-van den Berg A
Leukemia
. 2001 Feb;
14(12):2240-6.
PMID: 11187915
Here we report the long-term results of the DCLSG protocols ALL-6 and -7 with special emphasis on the incidence of CNS relapse after treatment without cranial irradiation. In DCLSG protocol...
12.
Kingma A, Rammeloo L, van der Does-van den Berg A, Postma A
Arch Dis Child
. 2000 May;
82(5):353-7.
PMID: 10799421
Aim: To evaluate academic career in long term survivors of childhood acute lymphoblastic leukaemia (ALL), in comparison to their healthy siblings. Patients: Ninety four children treated for ALL with cranial...
13.
van Dongen J, Seriu T, Panzer-Grumayer E, Biondi A, Corral L, Stolz F, et al.
Lancet
. 1998 Dec;
352(9142):1731-8.
PMID: 9848348
Background: Sensitive techniques for detection of minimal residual disease (MRD) at degrees of one leukaemic cell per 10(3)-10(6) cells (10(-3)-10(-6)) during follow-up of children with acute lymphoblastic leukaemia (ALL) can...
14.
Kaspers G, Pieters R, van Zantwijk C, van Wering E, van der Does-van den Berg A, Veerman A
Blood
. 1998 Jun;
92(1):259-66.
PMID: 9639525
As an important determinant of response to chemotherapy, accurate measurement of cellular drug resistance may provide clinically relevant information. Our objectives in this study were to determine the relationship between...
15.
Kaspers G, Veerman A, Pieters R, van Zantwijk C, Smets L, van Wering E, et al.
Blood
. 1997 Nov;
90(7):2723-9.
PMID: 9326239
As an important determinant of the response to chemotherapy, measurements of cellular drug resistance may provide prognostically significant information, which could be useful for optimal risk-group stratification. The objective of...
16.
Schouten L, van der Does-van den Berg A, Otter R, Coebergh J
Eur J Cancer
. 1997 May;
33(6):891-4.
PMID: 9291811
In the Netherlands, childhood leukaemia is recorded by the Dutch Childhood Leukaemia Study Group (DCLSG, set up in 1972) and by nine regional cancer registries which together form the Netherlands...
17.
Kaspers G, Veerman A, van Wering E, van Zantwijk C, van der Does-van den Berg A, Pieters R
Leukemia
. 1996 Apr;
10(4):675-81.
PMID: 8618446
We previously reported the favorable prognosis associated with positive peanut agglutinin (PNA) binding in childhood T cell acute lymphoblastic leukemia (ALL), and hypothesized that this may be related to glucocorticoid...
18.
Coebergh J, van der Does-van den Berg A, Hop W, van Weerden F, Rammeloo J, van Steensel H, et al.
Eur J Cancer
. 1996 Feb;
32A(2):286-9.
PMID: 8664043
We studied the effect of parental educational level (PEL), an indicator of socio-economic status (SES), on survival of children with acute lymphoblastic (ALL) and non-lymphoblastic leukaemia (ANLL). All children with...
19.
Smets L, Slater R, van Wering E, van der Does-van den Berg A, Hart A, Veerman A, et al.
Med Pediatr Oncol
. 1995 Dec;
25(6):437-44.
PMID: 7565305
DNA per cell content was routinely recorded by single-parameter flow cytometry in leukemic blasts from 473 children with acute lymphoblastic leukemia (ALL), enrolled in national studies ALL V, VI, and...
20.
van der Does-van den Berg A, de Vaan G, van Weerden J, Hahlen K, Veerman A
Pediatr Res
. 1995 Nov;
38(5):802-7.
PMID: 8552452
Late events and side effects are reported in 392 children cured of leukemia. They originated from 1193 consecutively newly diagnosed children between 1972 and 1982, in first continuous complete remission...